Oct 25 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2019 Sep 30, 2018 Mar 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.28 2.25 5.00
(+1.0 pct) (+12.4 pct) (+7.0 pct)
Operating 321 mln 307 mln 550 mln
(+4.7 pct) (+89.8 pct) (-5.4 pct)
Recurring 321 mln 324 mln 550 mln
(-1.1 pct) (+80.4 pct) (-7.8 pct)
Net 221 mln 219 mln 380 mln
(+0.7 pct) (+72.9 pct) (-1.5 pct)
EPS 54.76 yen 53.59 yen 103.00 yen
Ann Div 15.00 yen 15.00 yen
-Q2 div NIL NIL
-Q4 div 15.00 yen 15.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T